Human Cytomegalovirus Less Prone to Mutation

Researchers have analysed immunocompromised patient blood samples and shown HCMV is not mutating any more than other DNA viruses.

The Human Cytomegalovirus (HCMV) was found to be less prone to mutation, giving hope for a successful vaccine development, said UCL researchers.

HCMV, a DNA virus and type of herpes virus, is one of the world's most common and widespread //human infections, affecting between 45% to 100% of the adult population, depending on age and geographic area. While generally asymptomatic, HCMV is a concern for pregnant women, their unborn babies and patients with a weakened immune system. However developing a vaccine has proved elusive.

Infectious mononucleosis / 'Mono'-Symptoms-Risk factors-Diagnosis-Treatment
Called also the kissing diesase, Mononucleosis is an infectious disease due to infection with the Epstein Barr virus of the herpes virus family.

‘HCMV mutation rates are similar to other DNA viruses, providing some reassurance for the development of vaccines, as unlike the hyperdiverse RNA viruses, HCMV is unlikely to mutate to evade vaccines. ’

Previous global research has shown that within a single individual HCMV has high genome (genetic) diversity, leading to theories that HCMV has a high mutation rate. Such a trait is normally seen in RNA viruses, such HIV or Hepatitis C, which in turn makes them hard to develop vaccines against.

Now using new viral genome sequencing, bioinformatic and modelling tools developed at UCL, researchers have analysed immunocompromised patient blood samples and shown HCMV is not mutating any more than other DNA viruses. Instead, the frequent occurrence of mixed-infections caused by genetically different HCMV strains leads to findings of high genome diversity within an individual.

The study, funded by the European Union, has been published in Proceedings of the National Academy of Sciences. Lead author, Professor Judith Breuer (UCL Division on Infection & Immunity), said: "It has been claimed that HCMV is as diverse as the more error prone RNA viruses such as HIV and Hepatitis C Virus and this has led to a lot of confusion in the field.

Introduction Of Infections
Birth defects are abnormalities, which occur before the birth of the baby and can be caused due to genetic, environmental and other unknown reasons.

"Using our novel genome sequencing and bioinformatics modelling approaches, we have shown that the apparently high HCMV diversity seen in some clinical samples is caused not by HCMV mutation rather it is due to frequent co-infection with multiple strains of HCMV.

New UCL sequencing tool

Cytomegalovirus: Reactivation Of This Virus Can Be Prevented After Stem Cell Transplantation
Reactivation Of a Cytomegalovirus After Stem Cell Transplantation Can Be Prevented Using This Technique.

Professor Breuer's work focuses on the application of next generation deep genome sequencing, helping uncover new virus characteristics.

The Breuer Lab has pioneered whole pathogen genome sequencing, by methods called 'targeted enrichment', to generate high quality whole viral genomes directly from clinical material, without the need for viral culture or polymerase chain reaction (PCR). She has combined these methods with cutting-edge bioinformatics including the newly developed Haplotype Reconstruction of Longitudinal Sequence Data (HaRoLD).

Therapists Lack Knowledge In Preventing Cytomegalovirus Transmission
Cytomegalovirus (CMV) is a leading viral cause of birth defects, which poses a greater threat to infants than Zika and there is no enough information on how to prevent it.

Developed at UCL, HaRoLD is a new computational tool that applies Bayesian mixture models to reconstruct the genome sequence of each individual virus present in a sample containing multiple viruses.

"This process is comparable to sorting several jigsaw puzzles that have been jumbled up together," added Professor Breuer.

"The new bioinformatics methods for re-constructing individual genome sequences from a mixed infection will allow us to identify the factors, including recombination, that drive HCMV evolution in a patient, providing a precision approach to managing infections."

Source-Eurekalert